Concepedia

Pandurang M. Kulkarni

PM

Statistics

Publications

40

Citations

2.1K

H-Index

22

Active since

1987

Affiliations

Eli Lilly (United States)(Current)

University of South Alabama

City College of New York

University of California, Santa Barbara

Pandurang M. Kulkarni is an author at Eli Lilly (United States) specializing in medicine, pharmacotherapy, and fluid dynamics.

Publications per year

1987–2023

40

Publications

40

A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis

Jean‐Jacques Body, Gregory Gaich, Wim H. Scheele et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 365 citations

Medicine, Pharmacotherapy, Bone Augmentation +16

Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study

Ethel S. Siris, Steven T. Harris, Richard Eastell et al. · Journal of Bone and Mineral Research · 2005 · 242 citations

Medicine, Oncology, Pharmacotherapy +17

Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response

Jean-Pierre Lindenmayer, Hong Liu‐Seifert, Pandurang M. Kulkarni et al. · The Journal of Clinical Psychiatry · 2009 · 163 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Axial and lateral particle ordering in finite Reynolds number channel flows

Katherine J. Humphry, Pandurang M. Kulkarni, David A. Weitz et al. · Physics of Fluids · 2010 · 136 citations

Engineering, Aerospace Engineering, Computational Fluid Dynamics +12

Suspension properties at finite Reynolds number from simulated shear flow

Pandurang M. Kulkarni, Jeffrey F. Morris · Physics of Fluids · 2008 · 122 citations

Engineering, Mechanical Engineering, Physics +17

1–5 of 40